Family Intervention for Black Teens With Type 1 Diabetes
Launched by WAYNE STATE UNIVERSITY · Feb 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program called The 3Ms 2.0, designed to help Black teenagers with type 1 diabetes manage their condition better. The program aims to improve how these teens control their blood sugar levels and strengthen relationships within their families while also reducing stress for their primary caregivers. The study will compare this new approach, which includes videos and text messages delivered through their parents' smartphones, to a standard educational program.
To participate, teens must be between the ages of 10 and 14, have been diagnosed with type 1 diabetes for at least six months, and have a primary caregiver who is willing to join the study. Both the teen and caregiver should be Black and live within 30 miles of a recruitment site. Participants can expect to receive support and resources through the program to help manage diabetes together as a family. This study is currently recruiting participants, so if you meet the criteria and are interested, there may be an opportunity to get involved and make a positive change for your family.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 10 years, 0 months - 14 years, 11 months
- • Diagnosed with Type 1 diabetes
- • Diagnosed for at least 6 months
- • Black
- • Primary caregiver willing to participate
- • Residence within 30 miles of a recruitment site
- • Caregiver ownership of an Internet-enabled device (cell phone, laptop or desktop computer, tablet, etc)
- Exclusion Criteria:
- • Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality)
- • Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis)
- • Inability to speak or read English
- • Child is in out-of-home placement
About Wayne State University
Wayne State University, a distinguished public research institution located in Detroit, Michigan, is committed to advancing health and science through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university leverages its robust academic resources and expert faculty to conduct clinical trials that aim to improve patient outcomes and contribute to the body of medical knowledge. Wayne State University fosters a rigorous research environment, ensuring adherence to ethical standards and regulatory compliance while striving to translate research findings into practical applications that benefit diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Washington, District Of Columbia, United States
Detroit, Michigan, United States
Memphis, Tennessee, United States
Patients applied
Trial Officials
Deborah A Ellis, Ph.D.
Principal Investigator
Wayne State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported